OpenAlex
PricingAboutJobs
Log inGet started
Work

FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation–Positive Non–Small Cell Lung Cancer

HTML

Year: 2016
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-15-2266
Authors: Dickran Kazandjian, Gideon M. Blumenthal, Weishi Yuan, Kun He, Patricia Keegan, Richard Pazdur
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: gefitinib, metastatic non-small cell lung cancer, EGFR mutation, exon 19 deletion, L858R mutation, FDA drug approval, companion diagnostics, objective response rate, progression-free survival, skin reactions, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2302518824
FWCI: 3.105
Cites: 36
Cited by: 262
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms